<DOC>
	<DOC>NCT01084980</DOC>
	<brief_summary>The hypothesis of this study is that tacrolimus reduces the proteinuria in adult patient with minimal change nephritic syndrome.</brief_summary>
	<brief_title>Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome</brief_title>
	<detailed_description>A pilot study for comparative clinical trial on the therapeutic effect of tacrolimus (Prograf capÂ®) in adult patient with minimal change nephritic syndrome.</detailed_description>
	<mesh_term>Nephrosis, Lipoid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>from 18yrs to 80 yrs , man and women Minimal change disease is diagnosed by kidney biopsy On screening, the patient shows that the level of urine protein/creatinine ratio is over 3.0 On screening, the patient shows that the serum albumin is below 3.0g/dL the patient sign on the concent form the patient have experience to take tacrolimus or cyclosporin for 1 month If it is the relapse of the nephrotic syndrome, before relapse, the maintenance dose of steroid is over 0.3 mg/kg/day steroid dependent or steroid resistant or frequent relapse case uncontrolled hypertension pregnancy or anticipate pregnancy with 6 month hypersensitivity to tacrolimus or macrolide acute hepatitis or the level of AST or ALT is over 2 times of normal range or the level of bilirubin is over 2.0 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>minimal change disease</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>corticosteroid</keyword>
</DOC>